| A Study of Pembrolizumab for Patients With Thymic Epithelial Tumor (NCT02607631) | Samsung Medical Center | 2015-11-01 |
| Video Feedback Intervention for Cognitively Impaired Older Drivers (NCT02600026) | Rhode Island Hospital | 2015-11-01 |
| Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD (NCT02652598) | Sheppard Pratt Health System | 2015-11-01 |
| Aspirin on CTCs of Advanced Breast and Colorectal Cancer (NCT02602938) | Zhejiang Provincial People's Hospital | 2015-11-01 |
| Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer (NCT02413853) | University of Southern California | 2015-11-01 |
| Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia (NCT01675154) | University of Texas Southwestern Medical Center | 2015-11-01 |
| Aerosol Deposition in Asthmatic Obese Women Using Heliox (NCT02620956) | Jacqueline de Melo Barcelar | 2015-11-01 |
| Trial of IMO-8400 in Adult Patients With Dermatomyositis (NCT02612857) | Idera Pharmaceuticals, Inc. | 2015-11-01 |
| Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris (NCT03003247) | Bausch Health Americas, Inc. | 2015-11-01 |
| Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer (NCT02619435) | National Cancer Institute, Naples | 2015-11-01 |
| Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma (NCT02410863) | Prof. Dr. med. Dirk Schadendorf | 2015-11-01 |
| Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes (NCT02617654) | Per-Ola Carlsson | 2015-11-01 |
| Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION) (NCT02615002) | Neurim Pharmaceuticals Ltd. | 2015-11-01 |
| OLAParib COmbinations (NCT02576444) | Joseph Paul Eder | 2015-11-01 |
| Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL (NCT02576561) | THEVAX Genetics Vaccine | 2015-11-01 |
| A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease (NCT02271503) | Impax Laboratories, LLC | 2015-11-01 |
| Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Morphine Analgesia in the Dental Model (NCT02123979) | East Carolina University | 2015-11-01 |
| A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection (NCT02604212) | Arrowhead Pharmaceuticals | 2015-11-01 |
| Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation (NCT02474927) | John F. McDyer, MD | 2015-11-01 |
| The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer (NCT02539017) | First Affiliated Hospital Xi'an Jiaotong University | 2015-11-01 |
| The Effects of N-acetylcysteine on Performance and Redox Homeostasis (NCT03121222) | Aristotle University Of Thessaloniki | 2015-11-01 |
| Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer (NCT02547987) | Mothaffar Rimawi | 2015-11-01 |
| Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor (NCT02562963) | Minghui Zhang | 2015-11-01 |
| Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms (NCT02056574) | NoNO Inc. | 2015-11-01 |
| 1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus (NCT02985099) | Government Dental College and Research Institute, Bangalore | 2015-11-01 |
| Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults (NCT02894840) | Mahidol University | 2015-11-01 |
| Melatonin Oral Gel for Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation (NCT02630004) | Spherium Biomed | 2015-11-01 |
| Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris (NCT02938494) | Bausch Health Americas, Inc. | 2015-11-01 |
| A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients (NCT02614560) | Seagen Inc. | 2015-11-01 |
| A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation (NCT02571101) | CTC Bio, Inc. | 2015-11-01 |
| Denosumab and MRI Breast Imaging (NCT02613416) | Alison Stopeck | 2015-11-01 |
| The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation (NCT02495662) | Leiden University Medical Center | 2015-11-01 |
| Honey in Idiopathic Dilated Cardiomyopathy (NCT02987322) | mamdouh abdulmaksoud abdulrhman | 2015-11-01 |
| Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients (NCT02431351) | Karyopharm Therapeutics Inc | 2015-11-01 |
| Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV (NCT02624180) | Johns Hopkins University | 2015-11-01 |
| Botulinum Toxin in Burning Mouth Syndrome (NCT02964728) | Presidio Ospedaliero Garibaldi-Centro | 2015-11-01 |
| Secukinumab for Treatment of Atopic Dermatitis (NCT02594098) | Icahn School of Medicine at Mount Sinai | 2015-11-01 |
| Comparing Mouth Rinses (and Chewing Gum) in Regard to Streptococcus Mutans Reduction (NCT02598778) | Montefiore Medical Center | 2015-11-01 |
| Bendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell Lymphoma (NCT02420210) | University of Chicago | 2015-11-01 |
| The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment (NCT02575092) | Fuling Central Hospital of Chongqing City | 2015-11-01 |
| A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB (NCT02615639) | Third Affiliated Hospital, Sun Yat-Sen University | 2015-11-01 |
| Sevoflurane in Subarachnoidal Haemorrhage (NCT02946437) | University of Zurich | 2015-11-01 |
| Dexmedetomidine Versus Propofol for Prolonged Sedation in Poly Traumatized Mechanically Ventilated Patients (NCT02606409) | Assiut University | 2015-11-01 |
| Effectiveness of Budesonide Nasal Instillation in a Vertex-to-floor Position (NCT02862509) | Khon Kaen University | 2015-11-01 |
| Prevention of Preterm Birth With a Pessary in Triplet (NCT02601443) | Federico II University | 2015-11-01 |
| POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC (NCT02845908) | Fujian Cancer Hospital | 2015-11-01 |
| Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB (NCT02326285) | AIO-Studien-gGmbH | 2015-11-01 |
| Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis (NCT02330653) | Stacy A. Kahn | 2015-11-01 |
| Alpha Lipoic Acid in Geographic Atrophy (NCT02613572) | University of Pennsylvania | 2015-11-01 |
| Ambroxol as a Treatment for Parkinson's Disease Dementia (NCT02914366) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2015-11-01 |
| Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers (NCT02720601) | New Mexico Cancer Research Alliance | 2015-11-01 |
| Lorcaserin Intra Venous Cocaine Effects (NCT02680288) | Midwest Biomedical Research | 2015-11-01 |
| Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD (NCT02599064) | RXi Pharmaceuticals, Corp. | 2015-11-01 |
| A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma (NCT02572167) | Seagen Inc. | 2015-10-31 |
| A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir (NCT02569710) | Alios Biopharma Inc. | 2015-10-31 |
| Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007) (NCT02573181) | Merck Sharp & Dohme LLC | 2015-10-30 |
| Acute Hip Fracture Study in Patients 65 Years or Greater (NCT02578095) | Viking Therapeutics, Inc. | 2015-10-30 |
| EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients (NCT02443688) | Celtaxsys, Inc. | 2015-10-30 |
| Panhematin for Prevention of Acute Attacks of Porphyria (NCT02922413) | The University of Texas Medical Branch, Galveston | 2015-10-30 |
| Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults (NCT02514070) | National Heart, Lung, and Blood Institute (NHLBI) | 2015-10-30 |
| Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis (NCT02503644) | Inventiva Pharma | 2015-10-29 |
| Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer (NCT02512458) | Hellenic Cooperative Oncology Group | 2015-10-29 |
| Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease (NCT02234934) | University of California, Los Angeles | 2015-10-29 |
| An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia (NCT02569398) | Janssen Research & Development, LLC | 2015-10-29 |
| Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule (NCT02380794) | Chinese University of Hong Kong | 2015-10-28 |
| Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014) (NCT02476890) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-10-28 |
| A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age (NCT02484703) | Hoffmann-La Roche | 2015-10-28 |
| ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer. (NCT02681523) | Imperial College London | 2015-10-28 |
| Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma (NCT02481310) | Northwestern University | 2015-10-28 |
| A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects (NCT02486406) | AbbVie | 2015-10-28 |
| PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo (NCT02537509) | Rennes University Hospital | 2015-10-27 |
| A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors (NCT02366312) | NYU College of Dentistry | 2015-10-27 |
| Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma (NCT02436707) | Canadian Cancer Trials Group | 2015-10-27 |
| Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis (NCT01955980) | Pari Pharma GmbH | 2015-10-27 |
| A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy (NCT02552277) | Celularity Incorporated | 2015-10-27 |
| Reduced Intensity Conditioning Transplant Using Haploidentical Donors (NCT02581007) | Northside Hospital, Inc. | 2015-10-26 |
| Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study (NCT03348241) | University of Science and Technology, Yemen | 2015-10-26 |
| Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved (NCT02530320) | Grupo Español de Investigación en Neurooncología | 2015-10-25 |
| Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A (NCT02600286) | University Hospital, Strasbourg, France | 2015-10-23 |
| Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer. (NCT02585388) | ARCAGY/ GINECO GROUP | 2015-10-23 |
| Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy (NCT02579616) | Eisai Co., Ltd. | 2015-10-23 |
| Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects (NCT02587520) | Sanofi Pasteur, a Sanofi Company | 2015-10-22 |
| A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders (NCT02494258) | Celgene | 2015-10-22 |
| Extended-release of Octreotide (LF-PB) for the Treatment of Seroma (NCT02668588) | Chemi S.p.A. | 2015-10-22 |
| Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) (NCT02559206) | Ironwood Pharmaceuticals, Inc. | 2015-10-22 |
| Study of Tumour Focused Radiotherapy for Bladder Cancer (NCT02447549) | Institute of Cancer Research, United Kingdom | 2015-10-21 |
| Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload (NCT02435212) | Novartis Pharmaceuticals | 2015-10-21 |
| Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study (NCT02265874) | Ohio State University | 2015-10-21 |
| Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer (NCT02482376) | Duke University | 2015-10-21 |
| A Pilot Study of TRV130 for the Treatment of Fracture Pain (NCT02520297) | Trevena Inc. | 2015-10-20 |
| Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer (NCT02440425) | H. Lee Moffitt Cancer Center and Research Institute | 2015-10-20 |
| Nivolumab in AML in Remission at High Risk for Relapse (NCT02532231) | M.D. Anderson Cancer Center | 2015-10-19 |
| A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer (NCT02384239) | University of California, San Francisco | 2015-10-19 |
| Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma (NCT02551991) | Ipsen | 2015-10-19 |
| Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency (NCT02199496) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-10-19 |
| A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma (NCT02519348) | MedImmune LLC | 2015-10-19 |
| A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting (NCT02413008) | ITF Research Pharma, S.L.U. | 2015-10-16 |
| [18F]FES PET/CT in Endocrine Refractory Breast Cancer (NCT02409316) | University of Pennsylvania | 2015-10-15 |
| Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal (NCT03584308) | Catalysis SL | 2015-10-15 |
| A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus (NCT02349061) | Janssen Research & Development, LLC | 2015-10-15 |